Immunologists at UNIGE have revealed a previously unknown anti-tumor role of CD4 T lymphocytes, marking a breakthrough that ...

A new study, published recently in Nature Communications, offers the first-ever map of which parts of Chikungunya virus ...

In order to meet the biological constraints, In this paper we consider a system of four equations which captures T-cell-HIV interactions. It describes the behavior of normal T cells, latently-infected ...

HIV-infected cells may initially associate directly with α 4 β 7+ CD4 + T cells through gp120-α 4 β 7 interactions, followed by engagement of CD4 and CCR5 by virus and subsequent infection.

Incomplete immune recovery despite sustained virologic suppression in patients with HIV was associated with increased risk for incident cancer.

The Australian researchers developed a novel mRNA-based technology capable of reaching the white blood cells where HIV lies ...

Discover how understanding your viral load and CD4 count puts you in control of HIV treatment and transforms confusing ...

In the fight against cancer, immunotherapy - which aims to boost the body's natural defences against cancer - is experiencing remarkable growth. Most of these treatments are based on CD8 T lymphocytes ...

Lenacapavir, the injectable drug developed by a US-based company, Gilead Sciences, was trialled (tested) in Uganda and South ...

HIV remains incurable but manageable. Johns Hopkins found a way to silence it long-term using a molecule from the virus ...

A new nanozyme-powered TB test improves detection in people with HIV, offering rapid, electricity-free diagnosis via a beetle-inspired chip.